Facts & Figures

Selected key financial figures

In EUR mio. 2022 2021 2020
Revenues 11.28 11.63 8.12
Operating result (EBIT) -4.91 -4.14 -5.82
Loss for the year -6.40 -5.89 -6.01
Cash and cash equivalents per 31.12. 8.18 5.80 9.21
Balance sheet total per 31.12. 22.29 21.34 23.50
Net cash flow 2.37 -3.40 -2.81
R&D expenses 6.91 7.50 5.94

Marinomed Corporate Presentation

Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com